WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010120266) HPV PARTICLES AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/120266    International Application No.:    PCT/US2009/004299
Publication Date: 21.10.2010 International Filing Date: 24.07.2009
IPC:
A61K 48/00 (2006.01), C12N 7/04 (2006.01), A61K 47/42 (2006.01), A61P 35/00 (2006.01), A61P 17/00 (2006.01)
Applicants: INSERM, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE [FR/FR]; 101 Rue De Tolbiac F-75013 Paris (FR) (For All Designated States Except US).
AURA BIOSCIENCES, INC. [US/US]; One Broadway, 14th Floor Cambridge, MA 02142 (US) (For All Designated States Except US).
COURSAGET, Pierre, L. [--/FR]; (FR) (For US Only).
TOUZE, Antoine, A. [--/FR]; (FR) (For US Only).
FLEURY, Maxime, J. J. [--/FR]; (FR) (For US Only).
COMBELAS, Nicolas [--/FR]; (FR) (For US Only).
DE LOS PINOS, Elisabet [ES/US]; (US) (For US Only)
Inventors: COURSAGET, Pierre, L.; (FR).
TOUZE, Antoine, A.; (FR).
FLEURY, Maxime, J. J.; (FR).
COMBELAS, Nicolas; (FR).
DE LOS PINOS, Elisabet; (US)
Agent: WALLER, Patrick, R.H.; Wolf, Greenfield & Sacks, P.C. Federal Reserve Plaza 600 Atlantic Avenue Boston, MA 02210-2206 (US)
Priority Data:
61/168,914 13.04.2009 US
Title (EN) HPV PARTICLES AND USES THEREOF
(FR) PARTICULES HPV ET UTILISATIONS ASSOCIÉES
Abstract: front page image
(EN)The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
(FR)La présente invention concerne des particules HPV modifiées pouvant être utilisées à des fins thérapeutiques. Des particules HPV modifiées peuvent être utilisées pour administrer des agents thérapeutiques, notamment des molécules ARNsi. Des particules HPV modifiées peuvent être utilisées pour le traitement de maladies ou d'affections du tissu muqueux, y compris l'infection par HPV (papillomavirus humain) et les tumeurs associées à l'HPV.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)